洛沙坦(ｌｏｓａｒｔａｎ)系美国杜邦公司和爱默克公司共同开发的非肽类血管紧张素Ⅱ受体拮抗剂,近年来,由于其具有高度的特异性和选择性而被欧洲许多国家所认可,并用于高血压的一线治疗。但在大量的临床应用中也暴露出该药的一些不良反应,值得引起重视,下面对此作简要综?.. Losartan, a non-peptide angiotensin II receptor antagonist developed by DuPont and Emerson, has been approved by many European countries for its high specificity and selectivity in recent years , And for first-line treatment of hypertension. However, in a large number of clinical applications also exposed some of the adverse reactions of the drug, it is worth attention, the following summary of this?